Cargando…

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?

BACKGROUND: In hepatocellular carcinoma (HCC) patients, intraarterial therapies are regularly employed as a bridge to liver transplantation to prevent tumor progression during waiting time. Objective of this study was to compare HCC recurrence after liver transplantation following TACE or radioembol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benkö, Tamás, König, Julia, Theysohn, Jens M., Schotten, Clemens, Saner, Fuat H., Treckmann, Jürgen, Radunz, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134704/ https://www.ncbi.nlm.nih.gov/pubmed/35619164 http://dx.doi.org/10.1186/s40001-022-00708-w

Ejemplares similares

Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment
por: Radunz, Sonia, et al.
Publicado: (2017)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy
por: Feng, Rui, et al.
Publicado: (2023)

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
por: Mohamed, Mostafa, et al.
Publicado: (2015)

Aspergillus Tracheobronchitis Causing Subtotal Tracheal Stenosis in a Liver Transplant Recipient
por: Radunz, Sonia, et al.
Publicado: (2013)

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
por: Chung, Sung Won, et al.
Publicado: (2023)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
por: Yang, Yi, et al.
Publicado: (2018)

Transarterial radioembolization for hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2016)

Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary
por: Aktas, Gokmen, et al.
Publicado: (2018)

Medical students’ education on organ donation and its evaluation during six consecutive years: results of a voluntary, anonymous educational intervention study
por: Radunz, Sonia, et al.
Publicado: (2015)

Novel implications in the treatment of hepatocellular carcinoma
por: Best, Jan, et al.
Publicado: (2017)

Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial
por: Seinstra, Beatrijs A, et al.
Publicado: (2012)

LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
por: Leyh, Catherine, et al.
Publicado: (2022)

A Comparison of the Outcomes of Transarterial Chemoembolization and Transarterial Radioembolization in the Management of Neuroendocrine Liver Metastases in Adults: A Systematic Review
por: Victory Srinivasan, Nishok, et al.
Publicado: (2023)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

Combining Immunotherapy with Transarterial Radioembolization
por: Balaban Genc, Zeynep Ceren, et al.
Publicado: (2023)

Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis
por: Lopez-Lopez, Victor, et al.
Publicado: (2023)

Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation
por: Kim, Sue Jin, et al.
Publicado: (2009)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma
por: Mohr, Isabelle, et al.
Publicado: (2022)

Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
por: Girardet, Raphaël, et al.
Publicado: (2020)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

Long-term outcome of third, fourth and fifth kidney transplantation: technical aspects and immunological challenges
por: Benkö, Tamas, et al.
Publicado: (2019)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Adel, Hatem, et al.
Publicado: (2023)

Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization
por: Haubold, Johannes, et al.
Publicado: (2020)

Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts
por: Zhu, Wenliang, et al.
Publicado: (2022)

Extrahepatic transarterial radioembolization to treat fibrolamellar hepatocellular carcinoma: A case report
por: Ljuboja, Damir, et al.
Publicado: (2020)

Radiometal-Labeled Chitosan Microspheres as Transarterial Radioembolization Agents against Hepatocellular Carcinoma
por: Chan, Hui-Wen, et al.
Publicado: (2022)

Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement
por: Şener, Nur, et al.
Publicado: (2023)

One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation
por: Benkö, T., et al.
Publicado: (2018)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
por: Fateen, Waleed, et al.
Publicado: (2017)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2017)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
por: Orlacchio, Antonio, et al.
Publicado: (2020)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sv5puha21c3lpi75vqfn8gg0du